PRIVI SPECIALITY CHEMICALS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,153 INR | -2.55% |
|
-12.85% | -2.29% |
Valuation
| Fiscal Period: März | 2019 | 2020 | 2022 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 18,102 | 16,309 | 73,379 | 46,217 | - |
| Enterprise Value (EV) 1 | 18,102 | 16,309 | 82,216 | 46,217 | 46,217 |
| P/E ratio | - | 9.25 x | 75.4 x | 35.3 x | 26.4 x |
| Yield | - | - | 0.11% | 0.17% | 0.17% |
| Capitalization / Revenue | 1.35 x | 1 x | 5.23 x | 2.35 x | 2.05 x |
| EV / Revenue | 1.35 x | 1 x | 5.23 x | 2.35 x | 2.05 x |
| EV / EBITDA | 8.29 x | 6.09 x | 37.9 x | 12.4 x | 10.9 x |
| EV / FCF | - | - | -24.1 x | 18.3 x | 20.8 x |
| FCF Yield | - | - | -4.14% | 5.48% | 4.81% |
| Price to Book | 3.14 x | 2.2 x | 9.03 x | 4.41 x | 3.8 x |
| Nbr of stocks (in thousands) | 39,063 | 39,063 | 39,063 | 39,063 | - |
| Reference price 2 | 463.4 | 417.5 | 1,878 | 1,183 | 1,183 |
| Announcement Date | 19-05-09 | 20-06-23 | 22-05-05 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2019 | 2020 | 2022 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | 13,410 | 16,306 | 14,037 | 19,669 | 22,583 |
| EBITDA 1 | 2,184 | 2,680 | 1,938 | 3,717 | 4,223 |
| EBIT 1 | - | 2,053 | 1,192 | 2,445 | 2,923 |
| Operating Margin | - | 12.59% | 8.49% | 12.43% | 12.94% |
| Earnings before Tax (EBT) 1 | - | 2,313 | 1,328 | 1,765 | 2,362 |
| Net income 1 | - | 1,763 | 973.8 | 1,308 | 1,751 |
| Net margin | - | 10.81% | 6.94% | 6.65% | 7.75% |
| EPS 2 | - | 45.14 | 24.93 | 33.49 | 44.82 |
| Free Cash Flow 1 | - | - | -3,039 | 2,532 | 2,225 |
| FCF margin | - | - | -21.65% | 12.87% | 9.85% |
| FCF Conversion (EBITDA) | - | - | - | 68.12% | 52.69% |
| FCF Conversion (Net income) | - | - | - | 193.58% | 127.07% |
| Dividend per Share 2 | - | - | 2.000 | 2.000 | 2.000 |
| Announcement Date | 19-05-09 | 20-06-23 | 22-05-05 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2022 Q1 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|
| Net sales 1 | - | - | 3,769 | 3,888 |
| EBITDA 1 | - | - | 475.8 | 585.7 |
| EBIT | - | - | - | - |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) | - | - | 406.7 | - |
| Net income | 1,169 | 249.5 | 299.1 | - |
| Net margin | - | - | 7.94% | - |
| EPS 2 | - | - | - | 5.740 |
| Dividend per Share | - | - | - | - |
| Announcement Date | 21-08-03 | 22-01-27 | 22-05-05 | 22-08-10 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2019 | 2020 | 2022 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt | - | - | 8,836 | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | 4.559 x | - | - |
| Free Cash Flow 1 | - | - | -3,039 | 2,532 | 2,225 |
| ROE (net income / shareholders' equity) | 17.7% | 26.8% | 12.7% | 13.3% | 15.5% |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share 2 | 147.0 | 190.0 | 208.0 | 268.0 | 311.0 |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | - | - | 3,086 | 302 | 500 |
| Capex / Sales | - | - | 21.99% | 1.54% | 2.21% |
| Announcement Date | 19-05-09 | 20-06-23 | 22-05-05 | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1,183
INR
Average target price
1,165
INR
Spread / Average Target
-1.53%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -2.29% | 554M | |
| +17.59% | 66.6B | |
| +0.84% | 48.75B | |
| +17.11% | 41.45B | |
| +22.26% | 26.74B | |
| +11.45% | 19.55B | |
| +5.08% | 18.21B | |
| -21.31% | 16.02B | |
| +4.07% | 15.62B | |
| -9.70% | 15.33B |
- Stock Market
- Equities
- PRIVISCL Stock
- Financials Privi Speciality Chemicals Limited